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Inorganic and carbon based nanomaterials are widely used against several diseases, such as cancer, 
autoimmune diseases as well as fungi and bacteria colonization. In this work, Santa Barbara Amorphous 
mesoporous silica (SBA), Halloysite Nanotubes (HNTs) and Multiwalled Carbon Nanotubes (CNTs) were 
loaded with fluoroquinolone Levofloxacin (LVF) to be applied as antimicrobial agents. The prepared via 
adsorption nanocarriers were characterized by Fourier-Transformed Spectroscopy, Scanning Electron 
Microscopy as well as High Pressure liquid Chromatography. In vitro release studies were carried out 
using Simulated Body Fluid at 37oC and data analyzed by various kinetic models showing slow dissolution 
over 12-24 hours. Antimicrobial studies showed improved antibacterial activity against Escherichia coli, 
Enterococcus faecalis, Listeria monocytogenes, Staphylococcus aureus, and Staphylococcus epidermidis 
compared to neat nanomaterials. CNTs were found to be the most promising candidates for LVF delivery 
and they were chosen to be further studied for their acute oral toxicity and histopathological examination 
using C57/Black mice. Histological examination depicted that drug loading did not affect mice organs 
morphology as well as hepatocyte degeneration, central vein degeneration and parenchymal necrosis 
scores. To conclude, the prepared nanomaterials present significant characteristics and can act as 
antimicrobial drug carriers; CNTs found to be safe candidates when orally fed to mice.
Keywords: Carbon nanotubes. Santa barbara amorphous. Halloysite nanotubes. Levofloxacin. Toxicity. 
Antimicrobial.
INTRODUCTION
Nanotechnology is still the emerging application 
field for biomedical and pharmaceutical technology 
applications. Nanomaterials are claimed to be promising 
in medical field especially as imaging agents or drug 
carriers due to their large surface area, improved tissue 
penetration, drug protection against degradation and 
control of drug administration (De Jong, Borm, 2008; 
Siafaka et al., 2016c). With the passage of time, inorganic 
nanoparticles consist of gold, silver or silica and carbon 
based nanomaterials like nanotubes, graphenes as well 
as fullerenes have been used as advanced drug delivery 
platforms. Graphene comprised from a mono-layer 
sp2-bonded carbon sheet whereas single-walled carbon 
nanotubes (SWCNTs) and multi-walled carbon nanotubes 
(MWCNTs) present a cylindrical tube shape of sp2 
carbon, which roll up single- or multi-layered graphene, 
respectively. They display several unique physical and 
chemical characteristics which categorized them as suitable 
candidates in nanomedicine field (Siafaka et al., 2016b,c). 
The major concern by the CNTs use is the possible toxicity 
which is undesirable for biomedical applications. It has 
been outlined that orally fed CNTs seems to be safe even 
for a high dose of up to 1000 mg/kg (Kolosnjaj-Tabi et al., 
2010). In most cases, CNTs have been used so as to deliver 
anticancer drugs (Son, Hong, Lee, 2016) or antifungal iD
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drugs (Pieńko et al., 2017). Although, CNTs present 
several properties, many researchers studied their possible 
use for antimicrobial applications. Generally, SWCNTs 
express stronger antimicrobial property than MWCNTs. 
The fact that synthesis of SWCNTs is more expensive than 
MWCNTs, imrpoving antimicrobial property of MWCNTs 
is mandatory. For this reason, a past study, employed the 
immobilization via poly(ethylene glucol) of cefalexin 
antimicrobial drug so as to improve the antimicrobial 
properties of MWCNTs (Qi et al., 2012). 
Recently, nanotubes of halloysite, a low-cost 
clay mineral that expressed numerous physicochemical 
properties have been introduced as controlled release 
drug carrier and other biomedical applications (Hanif 
et al., 2016; Leporatti, 2017). In particular, halloysite 
nanotubes are natural green clays presenting a cylindrical 
structure with high aspect length–diameter ratio. Toxicity 
of HNTs has not been reported yet and claimed as 
biocompatible and thus can be used as drug delivery 
carriers. Antimicrobial carriers of HNTs have been 
reported in literature. In a recent study, HNTs were loaded 
with Vancomycin and further encapsulated in Alginate and 
Gelatin/Alginate gels as wound dressings to sustain the 
drug release (Kurczewska et al., 2017). Another research 
team evaluated the enhanced antibacterial activity against 
Escherichia coli incorporating halloysite nanotubes 
(HNTs) and silver into zinc oxide nanoparticles, since neat 
HNTs exhibit normal bacteria growth (Shu et al., 2017).
Silica based mesoporous materials like SBA-15 
(Santa Barbara Amorphous), MCM (Mobil Composition 
of Matter)) and MCF (Mesoporous Cellular silica Foams) 
are widely found in the literature considering their large 
surface volume ratio as well as straight narrow channels 
which allow active molecules (drugs, proteins etc) to 
highly be absorbed into their structures (Hudson et al., 
2008; Ukmar, Planinšek, 2010). In further, SBA-15 
mesoporous silicas are also in a considerable interest due 
to their great adsorption applications such as removal and 
determination of many molecules. Additionally, SBA-15 
cytotoxicity toward B14 fibroblasts was criticized as low 
(Ferenc et al., 2015). The current years, such nanostructure 
mesoporous materials have been investigated as drug 
carriers especially for anticancer drugs (Rajabi, Fayyaz, 
Luque, 2017), antifungal or anti-inflammatory and 
immunosuppressant agents (Ortiz-Bustos et al., 2017). 
Recently, SBA-15 loaded with Ampicillin, a known 
antibiotic drug was produced, expressing a burst release of 
the drug from the matrix (Nairi et al., 2017). Additionally, 
another team researched SBA-15 loaded with Vancomycin 
or Rifampin as well as a combination of those. They 
applied them against S. aureus and S. epidermidis 
indicating a statistically significant reduced biofilm density 
and fewer viable bacteria (Aguilar-Colomer et al., 2017). 
In this work in order to enhance antimicrobial 
properties of MWCNTs, SBA-15 and HNTs, Levofloxacin 
(LVF) as model drug was chosen. Fluoroquinolones such 
as LVF have been extensively employed in genitourinary, 
respiratory, sinus and skin tract infections management 
(Siafaka et al., 2016a). Researchers have been proposed 
several nanocarriers for LVF loading, such as polymeric 
nanoparticles (Karavolos, Holban, 2016), niosomal 
carriers, nanofibrous matrices, thermosensitive gels (Alves 
et al., 2016) etc. However, to the extent of our knowledge 
non applications of carbon based nanomaterials, 
or halloysite nanotubes and SBA-15 loaded with 
Levofloxacin have been found.
Therefore, the aim of this work was the evaluation 
of these nanomaterials as oral carriers for Levofloxacin. 
For this purpose, SBA, HNTs and CNTs containing LVF 
were produced and examined for their in vitro release 
and antibacterial property. CNTs loaded with LVF were 
concluded as the best candidate was orally administered 
to C57/Black mice to further evaluate the oral toxicity. 
MATERIAL AND METHODS
Material
Pluronic P-123 triblock copolymer, tetraethyl 
orthosilicate (TEOS) used for SBA preparation, 
multiwalled Carbon Nanotubes (CNTs), Halloysite 
nanotubes (HNTs) and Levofloxacin (LVF) were 
purchased by Sigma-Aldrich Chemical Co (Steinheim, 
Germany). All of the used solvents and reagents were of 
analytical grade.
Synthesis route of SBA-15 
The SBA-15 mesoporous silica was synthesized in 
accordance to previous reports (Karakoulia, Triantafyllidis, 
Lemonidou, 2008). Accordingly, Pluronic P-123 
copolymer was solubilised in aqueous hydrochloric acid 
(HCL) (1M, pH ≤ 1) at 35oC. Afterwards, addition of 
TEOS followed and the solution was magnetically stirring 
for 60 minutes. The solid particles obtained by filtration, 
washed with distilled H2O, calcinated in air (550oC, 6 hrs) 
and mesoporous silica was produced. 
Adsorption of the drug onto the nanocarriers 
Similarly to a previous work (Filippousi et al., 
2015), 200 mg of LVF was dissolved in 200 ml of 
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Acetonitrile/Methanol (ACN/MeOH) (10/90). Then, 
200 mg of SBA, CNTs and HNTs were added to the drug 
solution. The suspension was magnetic stirring under 
nitrogen atmosphere for 24 h. Following the solutions were 
centrifuged and washed with ethanol in order to remove 
the unloaded LVF particles from the SBA, HNTs or CNTs 
surface. In order to identify the adsorption the supernatants 
were quantified using HPLC system and the % adsorption 
was calculated, given the known LVF concentration.
Characterization of the LVF loaded nanomaterials
Fourier-Transformed Infrared Spectroscopy 
The interactions between carriers and LVF drug 
were examined via FT-IR spectroscopy study. FTIR–
spectrometer (model FTIR–2000, Perkin Elmer, Turkey) 
was used so as to record the baseline corrected spectra, 
with an area ranged from 4000 to 400 cm–1, of neat 
nanomaterials and loaded with LVF formulations. The 
resolution set of 2 cm–1 (32 co–added scans).
Scanning Electron Microscopy (SEM)
The morphology of the pristine and LVF loaded 
nanomaterials was performed by using a Zeiss EVO 
scanning electron microscope (SEM). The accelerating 
voltage was 20 kV, probe current was 45 nA and 
counting time was 60 s. All the data were analyzed via 
Digimizer software in order to assess the mean diameter 
of nanocarriers.
In vitro drug release 
In vitro release study of the LVF loaded nanocarriers 
was performed in simulated body fluid at 50 rpm. 100 
mg of the formulations were added into 100 mL pH 7.4 
Simulated Body Fluid (SBF) solution (Siafaka et al., 
2015) with a preserved temperature at 37±0.5°C to imitate 
body temperature. 0.5 mL of sample was removed at a 
predetermined time interval of 15 minute to 24 h while 
same volume of fresh medium was replaced. The analysis 
of the drug content was performed with HPLC. The HPLC 
system (HP Agilent 1100) consisted of a gradient pump 
and a UV detector set at 295nm.The used column was a 
C18, 120 A, 5μm, 250mm×4.6mm and column temperature 
was 25oC. The mobile phase comprised from H2O (pH=3) 
/ MeOH–(60/6400). The applied injection volume was 
10μL. Calibration curve was constructed by using different 
concentrations of LVF solution (1, 2, 5 10, 25 and 100 ppm) 
obtained by dilution with mobile phase of a stock aqueous 
solution of 200 ppm LVF (Siafaka et al., 2016a). 
Analysis of release data
In order to understand the possible release 
mechanism of LVF drug, the data from in vitro drug release 
studies was exposed to various mathematical models. The 
best-fit model was decided based on the highest regression 
values (r2) for correlation coefficients for formulations. 
For the evaluation and the determination of the release 
mechanism, kinetic models like zero order, first order, 
Higuchi and Hixson Crowell were applied. The analysis 
was utilized to the release study of drug performed until 
the 60-80% of drug released. In addition, Korsemeyers-
Peppas equation was also used for kinetic analysis. When 
the mechanism is Case I (Fickian) diffusion, it is very well 
known that the “n” value is around 0.5 (the exact value 
depends on the geometry). A value between 0.5 and 0.89 
reveals anomalous (non-Fickian) diffusion and a value of 
0.89 and above demonstrate a Case II Transport. When the 
release mechanism is mainly based on Fickian diffusion, 
a dimension less expression of the Higuchi model can be 
applied (Siafaka et al., 2016a).
Disc diffusion method
Escherichia coli ATCC 25922, Enterococcus faecalis 
ATCC 29212, Listeria monocytogenes ATCC 7644, 
Staphylococcus aureus ATCC 25923, and Staphylococcus 
epidermidis  ATCC 12228 were used to evaluate 
antibacterial activity of formulations by performing 
disk diffusion method. All microorganism samples were 
incubated 24 hours using brain-heart infusion (BHI) broth 
medium at 37°C. Following incubation, bacteria adjusted 
to 0.5 McFarland turbidity standards (108cfu/mL) with 
McFarland Densitometer (DEN-1, Biosan) in 0.85% 
sterile saline solu tion. Microbial suspension was cultured 
on Mueller Hinton agar (MHA) medium using a swab. 
The entire surface of the Mueller-Hinton Agar (MHA) 
petri dish was covered with the required inoculum using 
a swab, and the petri dish was air dried for 15 min. In a 
sterile environment, formulation discs were applied 5µL 
of every formulation were taken by forceps and placed 
on surface of the petri dish. 15 minutes later, dishes were 
incubated at 37°C for 24 h. Zone diameters occurred 
around the discs were measured, recorded and the results 
were evaluated. The study was conducted as pair-parallel 
manner (Üstündaǧ-Okur et al., 2014).
Acute oral toxicity study
Animals
For this study, CNTs loaded with LVF were chosen 
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as oral optimal candidate and study for their safety 
profile. Healthy mice were applied for the acute oral 
toxicity research. In fact, 21 healthy males and females 
C57/Black mice with weight of 25 g to 30 g and age of 
8 to 10 weeks obtained from the MEDİTAM, Istanbul 
Medipol University. The experiments were carried out 
according to Declaration of Helsinki for the procedure 
of animals in study. The experimental procedure relating 
to the animals was authorized by Istanbul Medipol 
University Ethical committee (No.27/12/2017-77) before 
the study started whereas it was conducted under the 
internationally accepted principles for laboratory animal 
use and care. 
Acute toxicity assay
Animal conditions
Mice located in a room at 22±2° C with constant 
humidity. A 12 light/12 dark cycle was used as commonly 
applied. In further, animals were acclimatized to laboratory 
conditions for a week prior to experiment start. They had 
free contact to food and water ad libitum. The mice were 
transferred to the laboratory 1 h before the test activated. 
All tests were completed between 09:00 and 12:00 h in 
normal room light and temperature (22±1 oC). Mice were 
separated to three groups of seven animals each (n=7), 
which were treated with the following: 
Group I: Blank CNT group, 
Group II: LVF loaded CNT group, 
Group III: Control group (Distilled water). 
Single doses of 2.8 mg/kg of blank and drug 
loaded CNT formulations were orally administered to 
both mice in the treatment groups. The formulations 
were suspended in a vehicle (distilled water). 0.5 mL 
of formulation was applied by oral gavage. More seven 
mice were administered with distilled water and named 
as the control groups. The mice were observed in detail 
for any indications of toxicity effect within the first six 
hours after the treatment period, and daily further for a 
period of 5 days. All animals were weighed and visual 
observations for mortality, behavioral pattern, changes in 
physical appearance, injury, pain and signs of illness were 
conducted daily during the period.
Measurement of liver weights
After 5 days period, all the mice were sacrificed and 
liver was isolated and examined for any lesions. In further, 
liver was weighed and their features were compared 
between both treated and control groups. 
Histopathological examination
Liver obtained from the mice were transferred 
in 10% neutral-buffered formaldehyde solution. After 
dehydration, the samples were blocked in paraffin. A 
microtome used to cut 5 µm. sections which further 
stained with hematoxylin and eosin. Mounted slides were 
evaluated under a light microscope (Nikon Eclipse Ni 
research microscope, Tokyo, Japan) and photographed 
using a digital camera (Microscope Digitale Camera 
DP70, Tokyo, Japan). The criteria for sections evaluation 
based on intensity and diffusion of degeneration and 
pleomorphism in hepatocytes, proliferation in bile 
duct, cytoplasmic eosinophily, parenchymal necrosis, 
degeneratin, congestion and thrombosis in central vein, 
and inflammation in portal space. Lastly, the counted 
values were summarized by each section whereas the 
degeneration degree was specified in accordance to a 
score system. Scoring was done as follow: 0-4 (no, low, 
moderate, high and very high, respectively as no staning 
(0), low (1+), moderate (2+), heavy (3+) and very heavy 
(4+). 
Statistical analysis
The statistical analysis was carried out via GraphPad 
Prism 7.0 software program. The results were pointed out 
as mean±standard error (SEM). Statistical significance 
among treated and non-treated groups was analyzed by 
one-way ANOVA followed by Dunnett’s post hoc test. 
P values<0.05 were considered statistically significant. 
Wherever significance has been confirmed, it is showed 
by *p < 0.05, **p < 0.01 and ***p < 0.001.
RESULTS AND DISCUSSION
Physicochemical characterization; FT-IR and SEM 
studies
FT-IR has been evaluated as one of the most important 
characterization technique used in pharmaceutical 
technology field. This is because with FT-IR several 
interactions between the drug and generally active 
molecules could be depicted. Consequently, herein the 
spectra of LVF, blank and drug loaded nanocarriers 
examined. FT-IR spectrum of LVF (Figure 1) exhibits 
at 2800-3100 cm-1 characteristic peaks due to aromatic 
group stretching, at 1730 cm-1 the stretching of carbonyl 
group whereas at 1294 cm-1 stretching of amines (C-N) 
is also revealed. The peak at 1085 cm-1 is correlated with 
C-halogen group presence while at region of 3274-3415 
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cm-1 hydroxyl groups of –COOH are illustrated (Siafaka 
et al., 2016a). 
It has been detailed that pure SBA-15 provides 
silanol groups on the channel walls, which can form a 
weak intermolecular hydrogen bond with drugs and further 
allow storage of high amount of a drug and also could 
prolong the drug release (Jangra et al., 2016). In case of 
neat SBA-15, the observed broad band at 3440 cm-1 is 
attributed to O-H bond stretching vibration of adsorbed 
water molecules, while at 1088 cm−1 can be also clearly 
identified the corresponding bending vibration mode 
(Figure 1a). For LVF loaded to SBA formulations, an 
alteration of the spectrum is specified. More specifically, 
many of the bands were shifted in lower wavenumbers due 
to interactions (hydrogen bonding) between the LVF and 
the mesoporous silica (Nanaki et al., 2017). 
The peaks observed in CNTs spectra at 1063, 1625 
and 3400 cm−1 are correlated with C−O, C=C and O−H 
bonds (due to water physically adsorbed), respectively 
(Figure 1a) (Farahani, Behbahani, Javadi, 2016). The 
band at 2980 and 2898 cm-1 is assigned to asymmetric 
stretching vibrations of ν(CH2). When LVF was absorbed 
an altered spectrum was seen due to possible interaction 
between LVF and the nanotubes (Filippousi et al., 2015). 
Moreover, the broad band at 3489 cm-1 corresponds to a 
higher absorbance because of LVF presence. 
In case of Halloysite nanotubes the spectra is defined 
as similar as in the literature reported. For instance, the 
absorptions bands at 3697 and 3623 cm-1 are due to the 
stretching vibration of the inner-surface of O-H groups of 
halloysite, respectively. The vibration at 1651 cm-1 depicts 
the interlayer water. The 1126 cm-1 peak is assigned to 
Si-O stretching, while the band at 1004 cm-1 corresponds 
to Si-O-Si stretching vibration. The band observed at 523 
cm-1 was due to the vibration of Al-O-Si. The vibration of 
the inner surface hydroxyl group at 908 cm-1 and Si-O-Si 
at 452 cm-1 confirm the existence of corresponding groups. 
In further, when LVF loaded to HNTs a shifting in lower 
wavenumbers was also observed indicating interactions 
between LVF and Si bands (Kurczewska et al., 2017).
SEM analysis was applied in order to morphologically 
examine the nanocarriers. For pristine CNTs a mean 
diameter of 36.8587±9.5491 nm was depicted. When LVF 
was absorbed onto these nanocarriers no morphological 
alterations was observed whereas drug crystals have not 
been identified. Given that, LVF drug was not crystallized 
and thus an increased release rate is found. 
SBA-15 mesoporous silicas particles are comprised 
from tubular mesopores in an ordered hexagonal array 
(Karakoulia, Triantafyllidis, Lemonidou, 2008). SEM 
study of the prepared SBA-15 indicated the appearance of 
a cluster of particles with mean diameter 449.5 ± 107.4 nm, 
which are aggregated forming larger clusters of 4-5 μm. 
FIGURE 1 - FT-IR spectroscopy studies for A) SBA-15 neat 
and loaded with LVF B) CNTs neat and loaded with LVF and 
C) HNTs neat and loaded with LVF.
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When LVF loaded to the SBA-15 a more compact form 
was achieved probably due to the drug loading. However, 
drug molecules were not observed indicating that drug did 
not crystallize. In case of HNTs a cluster of tubular shaped 
particles is investigated. As follows, tubes with a mean 
diameter of 99.18±26.31 nm are observed. Nonetheless, 
the cluster of these particles presents a diameter of 2μm. To 
conclude, when the drug was absorbed the HNTs structure 
did not affected.
In vitro release and data analysis
It has been reported that Levofloxacin is hydrophilic 
drug. In most cases, hydrophilic drugs express high drug 
loading however in this work, the drug loading is mostly 
accelerating by other parameters. When nanomaterials 
with high surface area ratios as CNTs, HNTs or SBA are 
used also drug loading is believed to be high. Accordingly, 
herein LVF was dissolved using ACN/MeOH solution 
and nanomaterials were dispersed in the solution in order 
to obtain high drug loading capacity. The isolation of 
the materials was achieved via centrifugation and the 
supernatants were quantified using HPLC in order to find 
LVF concentration. Table I exhibited the results of the 
LVF adsorbed nanomaterials. It can be concluded that 
SBA presents the higher drug loading (23.64%) possibly 
because of the interactions between LVF and silanol 
groups, following by CNTs (10.1%) whereas HNTs 
absorbed only 2.6% of the drug.
Currently, Levofloxacin has been approved as oral, 
ocular or injectable systems by FDA. LVF is a highly 
hydrophilic active pharmaceutical ingredient (API) and 
for this reason was fully dissolved within the first 2 h (data 
are not shown). However, when the drug is absorbed in the 
nanocarriers, a slower release rate is observed (Figure 3). 
It is reported that incorporating a hydrophilic drug onto 
FIGURE 2 - SEM analysis for A) pure CNTs (original magnification valueX100), B) CNTs loaded with LVF(original magnification 
valueX100), C) pure SBA-15(original magnification valueX50), D) SBA-15 loaded with LVF(original magnification valueX50), 
E) pure HNTs (original magnification valueX55), and F) HNTs loaded with LVF(original magnification valueX55).
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nanomaterials, porous or not, a slower release rate can be 
achieved. Nonetheless, in almost all cases a burst effect 
is accomplished (Filippousi et al., 2016; Filippousi et al., 
2015). 
In this study, a low burst phenomenon can be 
seen for all the nanocarriers, which can be interpreted 
in regards to the drug deposition on the surface of the 
nanocarriers. After the initial immediate release, a slower 
rate is observed. For instance, in case of SBA a more 
vigorous rate can be observed and 100% of the drug is 
released in 12 hours. In detail, in 1 hour 37% of LVF 
was dissolved whereas after 2 hours of dissolution, SBA 
released almost the 70% of LVF. Finally, 12 hours later 
complete dissolution is observed. Among others, SBA-15 
can control the drug release due to its gate like scaffold 
nature in pure and in functionalized form (Jangra et al., 
2016). This reduce on dissolution rate is important since 
an immediate high drug dosage can be toxic to the living 
organism and thus controlling the rate and administration 
can be very effective. 
Likewise, in case of carbon nanotubes more 
sustained release is depicted. For instance, after 1 hour 
almost 23% of LVF was dissolved, in 2 hours dissolution 
reached at 40% and complete release was achieved after 24 
hours. Compared to these nanocarriers, HNTs dissolution 
profile is completely different. In fact, the first 2 hours 
of examination only 7% of the drug was released and in 
24 hours release rate reached 30%. These observations 
are rational given that HNTs are used in the literature as 
controlled release formulations (Cavallaro et al., 2017). 
Many past studies examine release mechanism of 
nanomaterials by various kinetic models. In most of the 
studies polymeric nanoparticles are evaluated for their 
mechanism. Diffusion and erosion are the main release 
mechanisms, found in drug delivery systems. In this 
work, the data from in vitro release studies of formulations 
were evaluated according to the zero order, first order, 
Higuchi and Hixson Crowell and Korsmeyer-Peppas 
kinetic models (Table II). According to the analysis of 
all mathematical models, it is clearly seen that first order 
model showed obviously a better fit for all formulations. It 
has been reported that first-order model is fitted in porous 
materials loaded with aqueous soluble drugs (Ortiz-Bustos 
et al., 2017).
Furthermore, to evaluate in vitro release kinetics 
of LVF, the Korsmeyer-Peppas model also examined for 
LVF loaded formulations. When n = 1, the release rate is 
non-dependent of time (zero-order) (case II transport). In 
TABLE I - Levofloxacin concentration (%) at filtrates and adsorbed into nanomaterials quantified by HPLC
CNTs SBA HNTs
Levofloxacin theoretical organic solution concentration (mg/mL) 1 1 1
Levofloxacin quantified at filtrate (%) 89.9 76.36 97.4
Levofloxacin adsorbed in nanomaterials (%) 10.1 23.64 2.6
FIGURE 3 - In vitro release studies of LVF from SBA-15, CNTs 
and HNTs.
TABLE II - Kinetic data of LVF release parameters obtained from formulations.
Models Zero order First order Higuchi Hixson-Crowell Korsmeyer-Peppas
Samples r2 n m r2 n m r2 n m r2 n m r2 n
CNTs+LVF 0.74 24.70 3.796 0.975 4.422 -0.13 0.922 2.34 22.266 0.913 0.364 0.124 0.924 0.79
SBA+LVF 0.74 29.05 9.775 0.954 4.395 -0.32 0.880 2.01 36.380 0.899 0.421 0.320 0.915 1.27
HNTs+LVF 0.97 2.863 1.138 0.982 4.579 -0.01 0.965 -2.59 5.991 0.979 0.042 0.020 0.883 0.76
P. I. Siafaka, M. E. Okur, Ş. Ayla, S. Er, E. Ş. Cağlar, N. Ü. Okur
Braz. J. Pharm. Sci. 2019;55:e18295Page 8 / 13
case of n = 0.5 a fickian diffusion is declared but when 
0.5<n<1.0 both means diffusion and non-fickian transport 
are involved. Lastly, in case of n > 1.0 super case II 
transport is apparent ’n’ is the slope value of log mt/m∞ 
versus log time curve (Üstündağ-Okur et al., 2015). 
In this study, CNTs and HNTs formulations exhibited 
anomalous (non-Fickian transport) diffusion mechanism 
with “n” values 0.794 and 0.763, respectively (Table II). 
The “n” value of SBA formulation has been found to be 
more than 1. This result indicates that the drug release 
from the matrix suggests super Case II transport given that 
these values are characteristic for mass transfer following 
a non-Fickian model, suggesting that the diffusion of the 
drug is restricted by the interactions among the drug and 
the surface silica species (Ortiz-Bustos et al., 2017). 
Antibacterial activity of LVF formulations
Levofloxacin, as it has been reported is a broad 
spectrum antibacterial agent used to treat numerous bacterial 
infections such as acute bacterial sinusitis, pneumonia, 
urinary tract infections, chronic prostatitis, and some types 
of gastroenteritis (Siafaka et al., 2016a). In addition, it can 
be used along with other antibiotics to manage tuberculosis, 
meningitis, or pelvic inflammatory disease. It has been 
reported that this fluoroquinolone derivative presents high 
bactericidal activity against M. Tuberculosis, P. aeruginosa, 
S. Aureus, Escherichia coli etc.
Herein,  the ant imicrobial  act ivi ty of  LVF 
loaded nanocarriers (Table III) was tested against four 
opportunistic pathogens commonly associated with 
oral and pulmonary disease: Staphylococcus aureus, 
Staphylococcus epidermidis, Enterococcus faecalis, 
Listeria monocytogenes. As it was expected the pristine 
nanocarriers did not express any bactericidal activity, 
although it has been claimed that carbon nanotubes could 
express antimicrobial activity. However, an inhibition 
growth was seen from HNTs to E.coli strain (8 mm). In 
the literature, neat HNTs did not exhibit any bactericidal 
activity used in its pristine form but when it was decorated 
with Ag or ZnO showed improved properties (Shu et al., 
2017). Statistically significant difference has not been 
pointed out for antibacterial activity between CNT and 
SBA against Staphylococus epidermidis, Escherichia 
coli, Staphylococus aureus, Listeria monocytogenes (p 
> 0.05). Zone inhibition diameters of LVF solution were 
determined as 22mm against Staphylococus epidermidis 
and Listeria monocytogenes (Figure 4). 
Moreover, a similar inhibition halo (20-32 mm) 
was observed in case of SBA-15 and MWCNTs loaded 
with Levofloxacin for all the studied strains revealing 
that antibiotic activity of such carriers is promising. For 
example, when SBA loaded LVF was applied against E. 
coli a higher inhibition halo (32mm) was found compared 
to CNTs loaded LVF (28mm) which however is not 
statistically significant. Nonetheless, CNTs loaded with 
LVF was superior against S. epidermidis, S. aureus and 
E. faecalis presenting 22, 28, 22 and 32 mm inhibition 
zone, respectively. SBA loaded LVF and CNTs loaded 
LVF showed same bactericidal ability in case of Listeria 
monocytogenes (20mm).
It has been revealed, that CNTs immobilized with 
Cefalexin exhibited also improved bactericidal activity 
(Qi et al., 2012). Similarly, a past study evaluated SBA-
15 loaded with Ag demonstrating increased antimicrobial 
activity against E. coli due to a synergistic action between 
extracellular ROS and the toxicity of Ag+, which induced 
intracellular ROS production and subsequent cell death 
(Wang et al., 2014). In case of HNTs, a slight decreased 
inhibition halo is seen which is associated with the 
controlled drug release of the nanocarriers. It can be 
concluded that compared to free LVF solution a 5% 






































SBA 0 0 0 0 0
SBA+LVF 20 32 18 20 24
CNTs 0 0 0 0 0
CNTs +LVF 22 28 20 20 32
HNTs 0 8 0 0 0
HNTs +LVF 12 22 12 12 20
LVFSOL 22 30 20 22 30
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reduction in the inhibition zone is seen, which it was 
expected due to the slower release rate and the difficulty of 
the drug to be diffused from the carrier (Islan et al., 2016). 
For the oral toxicity experiment test, CNTs formulations 
were chosen as the most promising formulations since 
they also showed better antibacterial activity properties.
Oral acute toxicity
From a scientific aspect, toxicity is the degree to 
which chemicals or other toxic substances can affect 
a living organism. Toxicity can have an impact either 
on a whole organism (animal, bacteria, and humans) 
but can also affect a substructure of the organism, such 
as cells (cytotoxicity) or a bodily organ like the liver 
(hepatotoxicity) or kidney (nephrotoxicity). Fortunately, 
living organisms can defend themselves against chemical 
exposure; for instance, via metabolism, distribution, and 
excretion various adverse effects can be determined and the 
risk can be overcome. Nonetheless, exposure in chemicals 
and drugs, due to renal clearance and detoxification mainly 
lead to kidney and liver injury (Björnsson, 2016). 
FIGURE 4 - Antibacterial activity of the blank and LVF loaded formulations.
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As it was referred in this work, CNTs blank and 
loaded with Levofloxacin were studied for their acute 
oral toxicity. Throughout literature, CNTs toxicological 
study reveals conflicting results. Some preliminary in vitro 
toxicological tests suggested that CNTs are toxicologically 
benign to certain cells, whereas other studies showed 
that CNTs, mostly raw materials have the potential of 
being dangerous to many organisms (He et al., 2013). 
In particular, although CNTs cytotoxicity is not always 
revealed by the cell culture assay, oxidative stress is 
the main cause of cytotoxicity (Patlolla, McGinnis, 
Tchounwou, 2011). 
The available safety data indicate that CNTs are of 
low toxicity via various exposure pathways for biomedical 
applications. In further, Pulskamp, Diabate and Krug 
(2007) demonstrated that CNTs did not express acute 
toxicity in pulmonary epithelial and macrophage cell 
lines (Pulskamp, Diabate, Krug, 2007). Additionally, an 
important parameter is the administration dose of CNTs. 
The most difficult part on CNT toxicokinetics examination 
is to compare the currently published data due to the 
differences among the materials. Parameters such as 
size, dispersibility, functionalization, and metal catalyst 
contaminants, can lead to discrepancies among toxicity 
results. Subsequently, detailed chemical and structural 
characterization of the nanomaterial has to always be given 
in toxicokinetics assessments of CNT. 
In this study, the mice from control and treated 
groups were orally fed with vehicles, blank and LVF 
loaded CNTs, respectively. A daily monitoring of the 
mice was done until 5th day in order to observe any 
toxic signs and mortality. It can be safely reported 
that toxic symptoms or mortality were not revealed 
for all animal groups which lived up to 5 days of the 
experimental period after treated with blank and drug 
loaded formulations using a single dose level of 2.8 
mg/kg body weight. During toxicity evaluation the 
observation of any clinical symptoms is one of the 
most significant parameter (Jothy et al., 2011). Mice 
behavioral patterns were evaluated the first 6 h and 12 
h after the administration. It was found that animals in 
control and CNTs treated groups were normal whereas 
their behavior, skin, eyes, mucous membrane, sleep, 
diarrhea, breathing, impairment in food intake and water 
consumption, postural abnormalities and hair loss have 
not shown any inconsistencies. Even more, body and 
liver weight was similar. In detail, in this study liver was 
not adversely affected throughout the treatment. The liver 
weight of mice between blank and drug loaded CNTs 
treated and control groups did not show any statistically 
significant differences (P > 0.05) (Figure 5).
Furthermore, histological examination was 
performed so as to investigate any alteration in cell 
structure of the organs. It is well reported that histological 
study is significant for the evaluation of pathological 
changes in tissues and organs  OECD/OCDE, 2008). In the 
present study, histopathological assessment of acute oral 
ingestion of formulations specified that the formulations 
did not adversely show impact in the morphology of mice 
organs. Further, macroscopic investigation of mice organs 
treated with CNTs did not show any alterations in color 
compared to control. Finally, autopsy at the end of the 
experiment did not point out obvious alterations in the liver 
from both control and treated mice. Figure 5 illustrates 
the microscopic structures of the organs implying 
unnoticeable differences between the control and treated 
mice groups. Likewise, CNTs treated mice organ did not 
display any changes in cell structure or any unfavorable 
effects when studied under the light microscope using 
multiple magnification power. It can be claimed that the 
structure or coordination of cells in CNTs treated organs 
are more or less similar compared with the control group 
organs. 
Table IV shows hepatocyte  degenerat ion, 
cytoplasmic eosinophilia, central vein degeneration and 
parenchymal necrosis scores of mice livers after treatment 
5 days with formulations and control group. All hepatocyte 
degeneration, cytoplasmic eosinophilia, central vein 
degeneration and parenchymal necrosis scores were found 
less than 1. Hepatocyte degeneration and parenchymal 
necrosis of blank and drug loaded CNTs were found as 
0.571. Blank and LVF loaded CNTs scores present same 
scores except cytoplasmic eosinophilia scores. It can be 
pointed out that the drug loading have not shown any effect 
FIGURE 5 - Comparison of liver weight of mice among groups. 
Statistically significant as compared to control; P<0.05 (*), 
P<0.01 (**), P<0.001 (***).
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on hepatocyte degeneration, central vein degeneration and 
parenchymal necrosis scores. 
CONCLUSION
This study aims to check suitability of CNTs, HNTs 
and SBA carriers as oral drug delivery pltaforms. The 
prepared LVF loaded formulations showed improved 
antibacterial property against several strains. FT-
IR spectroscopy revealed interactions between the 
nanocarriers and the LVF drug while SEM images indicate 
slight alteration of their morphology after drug loading 
in case of SBA carriers. From the preliminary studies, 
LVF loaded CNTs were selected as best formulation. 
Histological examination of CNTs loaded with LVF 
showed that drug loading did not affect the hepatocyte 
degeneration, central vein degeneration and parenchymal 
necrosis scores. In further, histopathological examination 
of acute oral ingestion of formulations illustrated that 
the formulations did not reveal adversely effects on the 
morphology of mice organs. To conclude, the above 
nanomaterials showed interesting characteristics and could 
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